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In the brain, the neurotransmitter glutamate is re-
moved from the synaptic cleft by (Na  K)-coupled
transporters by an electrogenic process. Moreover,
these transporters mediate a sodium- and glutamate-de-
pendent uncoupled chloride conductance. In contrast to
the wild type, the uptake of radiolabeled substrate by
the I421C mutant is inhibited by the membrane-im-
permeant [2-(trimethylammonium)ethyl]methanethio-
sulfonate and also by other sulfhydryl reagents. In the
wild-type and the unmodified mutant, substrate-
induced currents are inwardly rectifying and reflect the
sum of the coupled electrogenic flux and the anion con-
ductance. Remarkably, the I421C mutant modified by
sulfhydryl reagents exhibits currents that are non-
rectifying and reverse at the equilibrium potential for
chloride. Strikingly, almost 10-fold higher concentra-
tions of D-aspartate are required to activate the currents
in the modified mutant as compared with untreated
I421C. Under conditions in which only the coupled cur-
rents are observed, the modified mutant does not ex-
hibit any currents. However, when the uncoupled cur-
rent is dominant, sulfhydryl reagents cause >4-fold
stimulation of this current. Thus, the modification of the
cysteine introduced at position 421 impacts the coupled
but not the uncoupled fluxes. Although both fluxes are
activated by substrate, they behave as independent pro-
cesses that are in dynamic equilibrium.
The major excitatory neurotransmitter in the brain is gluta-
mate. Transporters remove the transmitter from the synaptic
cleft so that its extracellular concentrations are maintained
below neurotoxic levels (1–5). Moreover, glutamate transport-
ers play an important role in limiting the duration of synaptic
excitation (6–9). Glutamate transport is an electrogenic proc-
ess (10–12) involving cotransport with sodium and hydrogen
ions followed by countertransport of potassium (13–15). The
stoichiometry of the process has been determined to be 3Na:
1H:1K:glutamate (3, 16).
The five known eukaryotic glutamate transporters, gluta-
mate transporter-1 (17), glutamate/aspartate transporter-1
(18), EAAC-1 (19),1 EAAT-4 (20), and EAAT-5 (21), have an
overall identity of approximately 50%. The homology is signif-
icantly higher in the carboxyl-terminal half. Glutamate trans-
porters have a non-conventional topology containing two reen-
trant loops, two transmembrane domains, as well as an
outward facing hydrophobic linker region (22–24), although
there remains some controversy over some of the features of
this topology (25). Two adjacent amino acid residues, tyrosine
403 and glutamate 404, of glutamate transporter-1 located in
transmembrane domain 7 and conserved in all other glutamate
transporters are required for potassium binding (15, 26). Two
other residues located in reentrant loop II and transmembrane
domain 7, respectively, have been found to be determinants of
sodium specificity (27, 28). Arginine 447 of the EAAC-1 trans-
porter located in transmembrane domain 8 and also fully con-
served in the other glutamate transporters appears to be a
determinant for the binding of the -carboxyl group of gluta-
mate and is also important for potassium interaction (29).
In addition to the ion-coupled glutamate translocation, glu-
tamate transporters mediate a thermodynamically uncoupled
chloride flux. It is activated by two of the molecules they trans-
port, sodium and glutamate (20, 30). This indicates the exist-
ence of a tight link between gating of the anion conductance
and permeation of glutamate. It has been suggested that this
capacity for enhancing chloride permeability may serve to off-
set the depolarization that occurs during glutamate transport
(20). In a very recent study (28), we have reported that in
EAAC-1, lithium can replace sodium in the coupled uptake but
not in its capacity to gate the glutamate-dependent anion con-
ductance. This finding suggests that the conformation gating
the anion conductance may be different from that during sub-
strate translocation. If this idea is correct, it should be possible
to selectively perturb one of the two fluxes mediated by the
glutamate transporters.
We have engineered externally accessible cysteines into
EAAC-1 with the aim of introducing fluorescent maleimides to
monitor conformational changes during transport. An analysis
of one of the mutants with a cysteine residue introduced in the
hydrophobic linker region revealed that the coupled uptake in
this mutant is very sensitive to sulfhydryl reagents. Strikingly,
the substrate-induced anion conductance is not affected at all
under these conditions. We have exploited the sulfhydryl-mod-
ified mutant to reveal novel properties of the substrate-gated
anion-conducting state and its relation to the coupled transport
cycle.
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Generation and Subcloning of Mutants—The rabbit glutamate trans-
porter EAAC-1 (19) with nine histidines added (29) in the vector pBlue-
scriptSK() (Stratagene) was used as a parent for site-directed mu-
tagenesis as described previously (31, 32). Restriction enzymes PinAI
and PflMI were used to subclone the mutations into the construct
containing the His-tagged wild-type EAAC-1 residing in either pBlue-
scriptSK() or in pOG2 (29). pOG2 is an oocyte expression vector con-
taining a 5-untranslated Xenopus -globin sequence and a 3-poly(A)
signal. The coding and non-coding strands were sequenced between the
above two restriction sites.
Expression and Uptake in HeLa Cells—HeLa cells were cultured in
supplemented Dulbecco’s modified Eagle’s medium (Biological Indus-
tries), infected with a recombinant vaccinia/T7 virus vTF7–3 (33), and
transfected with 0.5 g of DNA/well using LipofectAMINE (2 g/well)
(Roche Molecular Biochemicals), and D-[2,3-3H]aspartic acid uptake
was measured as described previously (28). For experiments using the
sulfhydryl reagent MTSET (Toronto Research Chemicals), culture me-
dium was removed, and the cells were washed twice with 1 ml of choline
uptake solution (sodium replaced with equimolar choline) and then
incubated with 200 l of uptake solution containing 500 M MTSET for
2 min. Cells were washed again twice in 1 ml of choline uptake solution
(37 °C) before the 10-min uptake assay was initiated by adding 200 l
of radioactive sodium uptake solution at 37 °C. Cells that did not
receive MTSET were subjected to the same incubation and washing
procedures. From dose-response experiments, the concentration of
MTSET giving half-maximal inhibition was determined to be 5 M (data
not shown). 100–5000  this concentration has been used on HeLa cells
and oocytes in initial experiments to rule out the possibility that MT-
SET reacts with wild-type EAAC1.
cRNA Transcription, Injection, and Oocyte Preparation—Capped
run-off cRNA transcripts were made from transporter constructs in
pOG2 and linearized with SacI using mMessage mMachine (Ambion),
and Xenopus laevis oocytes were prepared using collagenase type 1A
(Sigma) or Blendzyme 3 (Roche Molecular Biochemicals) and injected as
described previously (28). Oocytes were maintained either in modified
Barth’s saline solution (88 mM NaCl, 1 mM KCl, 1 mM MgSO4, 2.4 mM
NaHCO3, 1 mM CaCl2, 0.3 mM Ca(NO3)2, 10 mM HEPES, pH 7.5, with
freshly added 2 mM sodium pyruvic acid and 0.5 mM theophylline)
supplemented with 10,000 units/liter of penicillin, 10 mg/liter strepto-
mycin, and 50 mg/liter gentamycin or in ND96-recording solution (see
below) supplemented with 1.5% heat-inactivated horse serum, 0.5 mM
theophylline, and 2.5 mM pyruvic acid.
Oocyte Electrophysiology—Currents were measured from X. laevis
oocytes using conventional two-electrode voltage clamp recording as
described previously (28). Penetrated oocytes were gravity-perfused
with ND96-recording solution (96 mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1
mM MgCl2, 5 mM HEPES-hemisodium, pH 7.5). Sodium chloride and
HEPES-hemisodium were replaced with equimolar choline chloride and
free acid HEPES or replaced with equimolar lithium chloride and free
acid HEPES in sodium replacement experiments (pH was adjusted to
pH 7.5 with Tris-OH in these solutions). In experiments using the
highly permeant thiocyanate anion (Fig. 6), 2 mM KCl was replaced by
20 mM KSCN, and the sodium chloride concentration was varied by
replacing NaCl with equimolar choline chloride. In these experiments,
the extracellular grounding electrode was placed in 2 M KCl and con-
nected to the recording chamber with an agar/2 M KCl bridge. Before
applying either of the sulfhydryl reagents, MTSET (Toronto Research
Chemicals) or -maleimidopropionic acid (Sigma), the flow was stopped,
and the reagent was added directly into the bath under voltage clamp.
Before applying the reducing agent, 1,4-dithiothreitol (DTT), directly
into the bath, the oocyte was unclamped, grounding electrode was
removed, and the flow was stopped. MTSET and/or DTT was allowed to
react for 2 min followed by an 10-min washout (in initial experiments
using higher MTSET and DTT concentrations the washout time was 20
min). The net current was measured before MTSET application, after
MTSET application, and after DTT application in that order. Both the
MTSET and the -maleimidopropionic acid stock solutions were made
in the recording solution to which it was added (in the case of maleim-
ide, pH was adjusted to 7.5 with NaOH) and kept on ice for up to 2 h,
and the DTT was made in 1 mM sodium acetate, pH 5.2. The final
concentrations in the bath of MTSET and DTT were 2.5–25 and 50 mM,
respectively, in initial experiments and later concentrations were 1 and
10 mM, respectively, as estimated from the measured chamber volume
in the presence of an oocyte. Unless stated otherwise, oocytes were
perfused in recording solution with or without 1 mM D-aspartate or
L-aspartate.
Data Analysis—Data have been normalized to account for variability
in expression level within and between different oocyte batches. Steady-
FIG. 1. Effect of MTSET on D-[3H]aspartate uptake in HeLa
cells expressing substitution mutants at position 421 of EAAC-1.
Aspartate uptake (10 min at 37 °C) in cells incubated with (dark bars)
or without (gray bars) 500 M MTSET was measured as described
under “Experimental Procedures,” using 2 Ci/ml D-[2,3-3H]aspartate
(18 Ci/mmol). The results are expressed as percent activity of the
untreated wild-type EAAC-1 and are means  S.E. of 6–9
determinations.
FIG. 2. Net currents in sodium medium mediated by D-aspartate in I421C-EAAC-1 transporters. Currents recorded in the absence of
D-aspartate during 250-ms voltage pulses from 100 to 40 mV subtracted from currents recorded during superfusion of 1 mM D-aspartate (net
current). The prepulse potential was 25 mV. Horizontal line indicates zero current level. The net currents were measured before MTSET
application (Control), after MTSET application (MTSET), and after MTSET application followed by DTT (MTSET then DTT). MTSET was used
at 5 mM, but similar results were obtained with 1 mM used on other oocytes. DTT was used at 10 mM. A typical experiment is shown (n  10).






















state net currents defined as (INDD-Asp  IND) were analyzed using
Clampfit6.05 and Origin6.1 (Microcal). The current-voltage relations
shown were obtained by averaging the net currents at each holding
potential from 218 to 248 ms. For representational purposes, the traces
of the net currents shown in Figs. 2 and 4 have been low pass-filtered
off-line using the boxcar algorithm (Clampfit). Concentrations of D-
aspartate or sodium giving half-maximal currents (EC50) were deter-
mined with the generalized Hill equation (28) using a fixed maximum
current (Imax), and the determined EC50 and Hill number (nH) were
used to generate the curves shown. Residuals were minimized with the
Levenberg-Marquehardt method. The build-in functions of Origin6.1
were used for statistical testing. Data are the means  S.E. of 3–10
oocytes from 2–4 different batches.
RESULTS
Inhibition of D-[3H]Aspartate Uptake in I421C by MTSET—
HeLa cells expressing the I421C-EAAC-1 mutant exhibit sim-
ilar rates of D-[3H]aspartate uptake as those in which the wild
type is expressed (Fig. 1). However, in contrast to the wild type,
this uptake is almost fully inhibited by preincubation of the
cells with 500 M of the impermeant sulfhydryl reagent MT-
SET (Fig. 1). The introduction of a serine or an alanine residue
at this position does not render EAAC-1 sensitive to MTSET
(Fig. 1). These observations indicate that the inhibition of up-
take in I421C-EAAC-1 is the result of the introduced cysteine
and renders unlikely the possibility that the introduction of a
cysteine at position 421 causes the transporter to expose an
endogenous cysteine that could mediate the inhibition by the
sulfhydryl reagent. When I421C-EAAC-1 is treated with a con-
centration of MTSET low enough (5 M) to retain significant
residual activity, the major impact is on maximal uptake (Vmax
 66  6% inhibition (n  3)). The apparent affinity for sub-
strate (Km) is essentially unchanged (27  5 and 25  4 M (n 
3)) for untreated and MTSET treated I421C, respectively. This
finding indicates that the inactivation of uptake by MTSET is
because of a progressive reduction of functional transporters.
Modification of the Substrate-gated Currents by Sulfhydryl
Reagents—It is well established that in sodium-containing me-
dia, the addition of acidic amino acid substrates to oocytes
expressing cloned glutamate transporters results in the activa-
tion of a current representing the sum of two currents. The first
is a non-reversing inwardly rectifying current reflecting the
coupled cycle, whereas the second is a reversing non-rectifying
anion conductance that is thermodynamically uncoupled (20,
21, 30). The reversal potential of the combined current depends
on the acidic amino acid substrate. L-Aspartate gives rise to the
reversal at less positive potentials than L-glutamate and D-
aspartate (28, 30). An analysis of the D-aspartate-induced cur-
rents of oocytes expressing I421C-EAAC-1 in the presence and
absence of MTSET reveals a remarkable result. Instead of
currents, which are inward at the range of membrane poten-
tials tested (100 mV to 40 mV), preincubation with 1 mM
MTSET results in currents that are almost symmetrical
around the holding potential of 25 mV (Fig. 2). The treatment
of the MTSET-modified mutant transporters with dithiothre-
itol, which is expected to restore the cysteine at the 421 posi-
tion, also restores the voltage dependence of the D-aspartate-
induced currents (Fig. 2). Similar results have been obtained
when L-aspartate-induced currents are monitored (data not
shown). Other sulfhydryl reagents such as (2-aminoethyl)-
methanethiosulfonate and -maleimidopropionic acid modify
the currents of I421C in a similar way as MTSET. As expected,
DTT is able to restore the current modified by (2-aminoethyl)-
methanethiosulfonate but not by -maleimidopropionic acid
(data not shown). Plotting the average current/voltage relation
FIG. 3. Voltage dependence of steady-state net currents before and after MTSET treatment. Voltage dependence of net D-aspartate
currents in oocytes expressing wild-type EAAC-1 (A) or I421C-EAAC-1 (B) before MTSET, after MTSET application, and after MTSET application
followed by DTT as indicated in the figure (n  10). Net currents at 100 mV ranged from 500 to 1000 nA (A) and from 300 to 620 nA (B).
FIG. 4. Net currents in lithium medium mediated by L-aspartate in I421C-EAAC-1 transporters. Currents recorded in the absence of
L-aspartate during 250-ms voltage pulses from 100 to 40 mV were subtracted from currents during superfusion of 1 mM L-aspartate. The
application order of MTSET (1 mM) and DTT (10 mM) was as described in the legend to Fig. 2. A typical experiment is shown (n  6).






















(I/V plot) of six oocytes shows that MTSET treatment of I421C
changes the behavior of the substrate-induced currents from
inwardly rectifying to ohmic. The currents observed after MT-
SET treatment reverse at 25 mV (Fig. 3B). DTT restores the
inwardly rectifying currents (Fig. 3B). In contrast, the I/V
relations of wild-type EAAC-1 are not affected by MTSET (Fig.
3A). It is of interest to note that the reversal potential of the
D-aspartate-induced currents of the MTSET-treated I421C
transporters is approximately 25 mV (Fig. 3B), very close to
the reversal potential of chloride (30). Moreover, the I/V rela-
tion in this mutant is reminiscent of those in glutamate trans-
porter-1 and EAAC-1 mutants, which are locked in the ex-
change mode (15, 26, 29) and therefore only exhibit the
uncoupled chloride conductance.
Additional evidence supporting the idea that the currents
observed with MTSET-modified I421C transporters solely rep-
resent the anion conductance is provided in Fig. 4. We have
very recently found that in the presence of lithium, EAAC-1
transporters mediate the coupled current only (28). If the cur-
rents from MTSET-modified I421C solely are the result of the
substrate-induced anion conductance, one would predict that in
lithium medium no current will be observed at all. Because net
D-aspartate currents in lithium medium are rather small, we
have displayed the currents obtained with L-aspartate. The
latter substrate gives rise to larger currents in lithium medium
(28). As can be seen in Fig. 4, MTSET-treated I421C transport-
ers do not exhibit any significant L-aspartate-induced currents
in lithium medium. Again, the effect of MTSET can be reversed
by DTT.
Characterization of the Substrate-gated Anion Conduct-
ance—The selective elimination of the coupled current in I421C
by MTSET allows us to study the substrate-activated gating of
the anion conductance in isolation from substrate transloca-
tion. One prediction is that the reversal potential of the current
should be independent of the concentration of D-aspartate, but
this would not be expected for the size of the current. Indeed, at
increasing D-aspartate concentrations, the reversal potential
remains the same (Fig. 5B). On the other hand, the size of the
current representing the opening of more chloride channels
increases with the increasing D-aspartate concentration (Fig.
5B). The dependence of the current of untreated I421C-EAAC1
transporters on the D-aspartate concentration is shown in Fig.
5A. It is inwardly rectifying and similar to that of wild-type
EAAC-1 with or without MTSET treatment (data not shown).
Also, the affinity of untreated I421C-EAAC-1 of 25 M is
similar to that of the wild type with or without the sulfhydryl
reagent (data not shown) (19). An analysis of the D-aspartate
concentration dependence of the currents reveals that in
MTSET-treated I421C, the apparent affinity for this substrate
is lowered by almost 10 times as compared with the untreated
mutant transporters (Fig. 5C). The Hill number for D-aspartate
is not changed (Student’s t test at the 0.05 significance level):
1.1  0.1 and 1.2  0.2 at 100 and 40 mV, respectively,
before treatment and 0.9  0.1 and 1.0  0.2 after treatment
with MTSET. In both cases the apparent affinity is voltage-
independent, at least at negative potentials where a direct
comparison is feasible (Fig. 5C).
We have taken advantage of the I421C mutant to address the
FIG. 5. Concentration dependence of D-aspartate-dependent steady-state net currents in I421C-EAAC-1. Voltage dependence of
steady-state net currents at the indicated concentrations of D-aspartate before (A) and after treatment with 2.5 mM MTSET (B). The dependence
of EC50, determined from (A) and (B), on voltage is displayed in C. Net currents at 100 mV ranged from 260 to 460 nA at 1 mM D-aspartate
(A) and from 330 to 460 nA at 3 mM D-aspartate (B). Data are means  S.E. of three oocytes.






















question of whether (as is the case for coupled flux) multiple
sodium ions are required to enable the substrate-gated anion
conductance. To amplify the anion currents, 20 mM thiocyanate
has been included in the perfusion medium, because its perme-
ability is 70-fold larger than that of chloride (30, 34). Fig. 6A
illustrates the I/V plots of the D-aspartate (3 mM) net currents
in MTSET-treated I421C-EAAC-1 transporters at varying so-
dium concentrations. Replotting these data versus the sodium
concentration shows a cooperative behavior at all voltages
tested (Fig. 6B). The sodium concentration, which gives rise to
half-maximal currents, are similar (Student’s t test at 0.05
significance level) at 100 mV and at 40 mV, namely 23.0 
0.4 and 23.3  0.3 mM (n  6), respectively. The same is true for
the Hill numbers 3.0  0.2 and 2.9  0.1 at 100 and 40 mV,
respectively (t test at 0.05 significance level). The data shown
in Fig. 6, A and B, are normalized currents. An examination of
the absolute net D-aspartate currents reveals the striking re-
sult that treatment with MTSET causes a marked stimulation
of both inward and outward currents (Fig. 6C) as shown here at
96 mM sodium. At 40 and 100 mV, the increase is 4.43 
0.31- and 2.56  0.17-fold, respectively (n  6). This result
indicates that when the anion conductance is the major com-
ponent of the current, blocking the coupled cycle enables the
transporter to reside longer in the conformation gating the
anion conductance.
DISCUSSION
Our studies show that in I421C-EAAC-1 transporters, which
otherwise behave identical to wild-type EAAC-1, sulfhydryl
reagents abolish the uptake of D-[3H]aspartate (Fig. 1) and
modify the substrate-induced currents (Figs. 2 and 3). The
characterization of those currents indicates that it is the cou-
FIG. 6. D-Aspartate steady-state net currents in I421C-EAAC1 in the presence of thiocyanate. A, voltage dependence of D-aspartate (3
mM) steady-state net currents at the indicated sodium concentrations after treatment with 1 mM MTSET. B, sodium dependence of the net
D-aspartate currents (data replotted from A). C, a typical experiment depicting the absolute currents at 96 mM sodium are shown before (Control)
and after MTSET (MTSET) application. Absolute net currents in 96 mM sodium ranged from 370 to 1156 nA and from 380 to -2002 nA before
MTSET application at 40 and 100 mV, respectively, and from 1551 to 4767 nA and from 818 to 4150 nA after MTSET application at 40
and 100 mV, respectively. Data are means  S.E. of nine oocytes from four different batches. Error bars are smaller than the symbols.
FIG. 7. Possible interrelations between coupled and uncou-
pled pathways. Depicted is the coupled pathway (steps 1–4) and the
two possible entry routes into the anion-conducting state outT*Na,Glu.
Further details are given under “Discussion.”






















pled flux that is affected. Whereas this flux is completely
absent, the substrate-gated anion conductance is not affected
by the sulfhydryl reagents (Figs. 2–4). We have used the
mutant to study the anion conductance in isolation of the
coupled current and obtained novel insights into the similar-
ities and differences among these processes as well as their
interrelation.
Possible pathways connecting coupled and uncoupled fluxes
are shown in Fig. 7. The sodium-coupled glutamate transloca-
tion with the participating potassium ion and proton omitted
for simplicity is represented by steps 1–4. After the binding of
sodium and glutamate on the extracellular side (step 1), the
translocation complex is formed. After translocation (step 2),
the substrates are released on the intracellular side (step 3).
The unloaded transporter binds potassium (not shown), and
after translocation to the outside (step 4), potassium is released
and the transporter is ready to start a new cycle. Because
glutamate as well as the other acidic amino acid substrates
gate the uncoupled anion conductance in a sodium-dependent
manner, most models (34–37) propose a transition step of the
outward-facing substrate-loaded transporter to an anion-con-
ducting state, outT*Na,Glu (Fig. 7, step A). According to this
scenario, the modification of the cysteine introduced at position
421 may be explained by a perturbation of either steps 2 or 3.
HeLa cells expressing mutants locked in the exchange mode in
which step 4 is impaired selectively still exhibit normal
D-[3H]aspartate uptake (15, 26). The complete inhibition of this
uptake in I421C-EAAC-1 by MTSET (Fig. 1) renders selective
inhibition of step 4 unlikely. The fact that the apparent affinity
for D-aspartate to activate the anion conductance in I421C is
almost 10-fold lower than that to activate the total current (Fig.
5C) can be easily accommodated by the alternative possibility
depicted in Fig. 7, step B. According to this proposal, the anion-
conducting state outT*Na,Glu can be reached without entering
the coupled cycle. An inherent assumption is that the mutation
has not somehow altered the apparent affinity of the uncoupled
process for D-aspartate. Because the voltage dependence and
the D-aspartate concentration dependence of the currents in the
untreated mutant are identical to that of the wild type, it is
likely that this assumption indeed is correct. Three sodium ions
are translocated with glutamate in the coupled cycle (3, 16).
Our study of the uncoupled flux indicates that this process also
may require multiple sodium ions (Fig. 6, A and B). Therefore,
one possibility is that two or three sodium ions bind to the
transporter, and subsequently the sodium-bound transporter
binds glutamate and enters either the coupled cycle or the
anion-conducting state.
The role of the anion conductance has been postulated to
counteract the depolarization caused by excessive glutamate
flux (20). At high extracellular glutamate levels, the magnitude
of this depolarization caused by the coupled process could be
relatively large. Under these conditions, glutamate is likely to
saturate the activation site of the anion conductance. Thus, at
the same time, the influx of chloride will be activated, and this
is expected to limit the depolarization. It is of interest that
sulfhydryl modification of I421C also abolishes substrate-sen-
sitive transient currents (Fig. 2). These transients probably
represent voltage-dependent conformational changes associ-
ated with the coupled transport cycle but not those occurring
during gating of the anion conductance.
The idea that the activation of the anion conductance is sepa-
rate from that of the coupled transport (Fig. 7, step B) is in
harmony with several recent independent lines of evidence. Ki-
netic experiments indicate that the onset of the uncoupled cur-
rent is delayed compared with that of the coupled current (35–
37), and the two exhibit different pH profiles (38) and cation
specificities (28). Furthermore, it has been found that Zn2 se-
lectively perturbs the two processes. In the EAAT-1 transporter
(the human homologue of glutamate/aspartate transporter-1),
Zn2 was found to inhibit the coupled but not the uncoupled
current (39), and the reverse is true for EAAT-4 (40).
The scheme shown in Fig. 7 indicates that regardless of
which of the two events in fact takes place, the steps of the
coupled flux should be in dynamic equilibrium with the confor-
mation gating the anion conductance. Selective blockade of the
coupled cycle at either step 2 or step 3 is expected to increase
the probability of entering the anion-gating conformation. The
experiments shown in Figs. 2 and 6 support this idea. Upon
modification of I421C with MTSET, the net outward D-aspar-
tate currents emerge at positive potentials (Fig. 2). Before the
addition of the sulfhydryl reagent, the current due to the cou-
pled flux, which is inward even at 40 mV, is almost balanced
by the outward current, which reflects the substrate-gated
anion conductance (30). Selective elimination of the coupled
current by sulfhydryl reagents reveals the outward anion cur-
rent. In the presence of the highly permeable thiocyanate, the
contribution of the anion conductance to the total current is
markedly increased. At positive potentials, this conductance
becomes the major component of the total current even before
the addition of MTSET (30, 34–36). The result of the sulfhydryl
modification is 4-fold stimulation of the anion-current (Fig.
6C) because of the enhanced probability of entering the confor-
mation gating the anion conductance. At potentials more neg-
ative than the reversal potential, the stimulation of the inward
current after MTSET treatment is approximately 2.5-fold, be-
cause two events now take place. The coupled current, which
contributes significantly to the inward current, is inhibited at
the same time as the anion current is stimulated.
Even though we have obtained new functional insights into
coupled glutamate translocation and substrate-gated anion
conductance, the structural basis of their possible interrela-
tions remains unclear. Our observations that the modification
of a cysteine residue introduced in the hydrophobic linker re-
gion selectively inhibits coupled flux suggest that this region
may be less important for the activation of the anion conduct-
ance. It has been suggested that the same translocation path-
way is used for both processes (30). An alternative speculation
is that the coupled glutamate flux occurs within a glutamate
transporter monomer, whereas the anion-conducting path-
way is formed in the space among the monomers in a pen-
tameric structure (41). If the latter idea is correct, one way to
identify the chloride-conducting pathway may be to search
for residues that participate in the formation of interfaces
between monomers.
Two groups have also documented that sulfhydryl modifica-
tion of cysteine replacement mutants of the related human
glutamate transporter EAAT-1 results in the elimination of the
coupled flux but not the uncoupled process. In one report (42),
the cysteine was introduced at a position corresponding to
residue 417 of EAAC-1, and in the other report (43), the cys-
teine replacement was at a position corresponding to EAAC-1
residue 420.
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